HLB Genex, Inc. Logo

HLB Genex, Inc.

Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.

187420 | KO

Overview

Corporate Details

ISIN(s):
KR7187420005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노1로 65(관평동), 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Genex, Inc. is a biotechnology company specializing in the development and production of customized enzymes and microbiome-based solutions. The company leverages proprietary R&D platforms, including Microbial Surface Display Technology for high-throughput screening and Recombinant Protein Expression for scalable manufacturing. Its product portfolio consists of industrial special enzymes, such as Lactase, Catalase, and Proteinase K used in molecular diagnostics, and bio-healthcare ingredients like Vitamin K2 and Phytosphingosine for nutritional and cosmetic applications. HLB Genex is also actively engaged in the research and development of microbiome therapeutics by discovering and engineering effector molecules from beneficial microorganisms.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 00:00
Capital/Financing Update
주권관련사채권의취득결정
Korean 37.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-07 00:00
Share Issue/Capital Change
전환가액의조정
Korean 12.7 KB
2025-07-07 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 13.3 KB
2025-06-30 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 18.3 KB
2025-06-26 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.6 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-05-21 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 25.4 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.8 MB
2025-05-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 240.1 KB
2025-04-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 239.0 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-04-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 239.0 KB

Automate Your Workflow. Get a real-time feed of all HLB Genex, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Genex, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Genex, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan
4575
Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel
CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany
27N0
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America
CGC
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America
CAPR
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea
214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America
CARM

Talk to a Data Expert

Have a question? We'll get back to you promptly.